Could a simple oxygen change help ICU patients breathe easier after tube removal?
NCT ID NCT05904652
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving high-flow oxygen through the nose just before removing a breathing tube is safe and acceptable for patients in intensive care with severe breathing problems. Only 2 patients took part, and the main goal was to see if a larger study is possible. The researchers compared this new approach to standard low-flow oxygen given after tube removal.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High flow nasal oxygen delivery device
- What this could lead to
- If successful, this could lead to a larger trial testing whether high-flow oxygen before tube removal reduces the need for re-intubation.
- What could go wrong
- This is a very small feasibility study with only 2 participants, so results are not generalizable. It is designed to test recruitment and safety, not effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participant aged 18 to 80 years old at time of recruitment to study) * Ventilated for greater than or equal to 48 hours with respiratory failure * Treating clinician agrees ready for a planned extubation (but pressure support ventilation, fraction of inspired oxygen less than or equal to 40 , positive end expiratory pressure less than or equal to 10 centimetres of water, Respiratory rate less than 20 breaths per minute) * Minimal secretions * Neurologically intact (In the opinion of the treating clinician, the participant is unlikely to fail extubation due to their neurological status) * Cardiovascularly stable (systolic blood pressure greater than or equal to 70 millimetres of mercury, heart rate less than or equal to 150 beats per minute) * Written informed consent Exclusion Criteria: * Cardiac Implant Device * Internal Neurostimulator * Unstable Spinal Fracture or Spinal Cord Injury * Body Mass Index \>50kg/m\^2 * Skin lesions or dressings over electrode belt site * Pregnancy or Lactating * Intercostal Chest Drain (at treating clinician's discretion) * Severe type II respiratory failure (arterial partial pressure of carbon dioxide greater than or equal to 12 kilopascals) * Severe acidosis (Hydrogen ion concentration greater than or equal to 80 nanomoles per litre) * Chronic respiratory disease limiting functional capacity (MRC breathlessness grade IV or V) * Severe heart failure (New York Heart Association Grade III or IV) * Decreased GCS * Cardiovascular instability (systolic blood pressure less than or equal to 69 millimetres of mercury or heart rate greater than or equal to 151 millimetres of mercury ) * Pulmonary embolism * Nasal obstruction * Previous bleomycin administration * Base of skull fracture * Life expectancy less than or equal to 3 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Critical Care Medicine, Queen Elizabeth University Hospital
Glasgow, Scotland, G51 4TF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a portable ventilator match hospital machines? trial puts them head to head
- Can a machine breathe better than a nurse? automated oxygen system tested in COPD
- A global effort to make moving critically ill patients safer
- Can a new ventilation mode keep lungs healthier after heart surgery?
- Can new home monitors keep tabs on breathing support without a clinic visit?
- Healing together: could a Couples-Based program ease ICU aftermath?